明德生物：关于增资并收购蓝怡（湖南）医疗器械有限公司股权的进展公告

Core Viewpoint - Mingde Bio announced the acquisition of a 51% stake in Hunan Lanyi Medical Equipment Co., Ltd. through a cash investment of 35.701 million yuan, marking a strategic move to enhance its market position in the medical equipment sector [1] Group 1: Acquisition Details - The acquisition involves an initial cash investment of 35.701 million yuan to acquire 51% of Hunan Lanyi's shares from Lanyi Technology Group Co., Ltd. [1] - Following the completion of the initial acquisition, Hunan Lanyi will become a subsidiary of the company and will be included in the consolidated financial statements [1] - The agreement stipulates that further acquisition of the remaining shares will occur if Hunan Lanyi meets specific operational conditions from 2026 to 2028 [1] Group 2: Corporate Governance - The company's board of directors has authorized the management to handle the specifics of the capital increase and share purchase [1] - The acquisition agreement was signed on the same day as the announcement, indicating a swift execution of the deal [1] - Hunan Lanyi has completed the necessary business registration changes and obtained a business license from the local market supervision authority [1]